ENDRA Life Sciences (NDRA) Other Non-Current Assets (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Other Non-Current Assets for 8 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 939.91% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 939.91% increase from a year earlier, with the FY2025 full-year figure at $365417.0, changed 0.0% from the prior year.
• Other Non-Current Assets was $3.8 million for Q2 2026 at ENDRA Life Sciences, up from $5986.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $3.8 million in Q2 2026 and troughed at $5986.0 in Q1 2022.
• A 5-year average of $535771.7 and a median of $365417.0 in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets soared 10709.97% in 2024 and tumbled 98.36% in 2026, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $502576.0 in 2022, then climbed by 24.68% to $626610.0 in 2023, then sank by 41.68% to $365417.0 in 2024, then changed by 0.0% to $365417.0 in 2025, then soared by 939.91% to $3.8 million in 2026.
• The last three Other Non-Current Assets figures came in at $3.8 million (Q2 2026), $5986.0 (Q1 2026), and $365417.0 (Q4 2025), per Business Quant data.